Indications and uses
relieves occasional constipation (irregularity) generally couses bowel movement in 6 to 12 hours
relieves occasional constipation (irregularity) generally couses bowel movement in 6 to 12 hours
shake well before using Do not exceed recommended dose Age Starting Dose Maximum Dose adults and children 12 years and older 2 to 3 teaspoonsfuls once a day preferably at bedtime; increase as needed or as recommended by a doctor 3 teaspoonfuls in the morning and 3 teaspoonfuls at bedtime nder 12 years of age ask a doctor ask a doctor
Sennosides 8.8mg
Laxative
laxative products for longer than 1 week unless directed by a doctor
if you have rectal bleeding or failure to have a bowel movement after use of a laxative.
These may indicate serious condition.
ask a health professional before use
In case of accidental overdose, get medical help or contact a Poison Control Center immediately.
| Age | Starting Dose | Maximum Dose |
| adults and children 12 years and older | 2 to 3 teaspoonsfuls once a day preferably at bedtime; increase as needed or as recommended by a doctor | 3 teaspoonfuls in the morning and 3 teaspoonfuls at bedtime |
| nder 12 years of age | ask a doctor | ask a doctor |
artificial and natural cherry flavor, citric acid, methylparaben, polyethylene glycol, propylene glycol, propylparaben, purified water, sodium citrate, sucralose
call 305-592-9216 or info@aldamapharm.com
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 702311 | sennosides 8.8 MG in 5 mL Oral Solution | PSN | 2 |
| 702311 | sennosides, USP 1.76 MG/ML Oral Solution | SCD | 2 |
| 702311 | sennosides 8.8 MG per 5 mL Oral Syrup | SY | 2 |
| 702311 | sennosides, USP 26.4 MG per 15 ML Oral Solution | SY | 2 |
| 702311 | sennosides, USP 8.8 MG per 5 ML Oral Solution | SY | 2 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 73564-812 | 73564-812-08 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| WATER | 059QF0KO0R | IACT |
| SUCROSE | C151H8M554 | IACT |
| PROPYLENE GLYCOL | 6DC9Q167V3 | IACT |
| METHYLPARABEN | A2I8C7HI9T | IACT |
| PROPYLPARABEN | Z8IX2SC1OH | IACT |
| SENNOSIDES | 3FYP5M0IJX | ACTIB |
| Version | Effective date | Source | Hydrated |
|---|---|---|---|
| 1 | 2026-01-23 | full-release | 2026-06-01 01:34:37 |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Senna Syrup | SENNOSIDES 8.8MG/5ML | Aldama Pharmaceuticals, Inc | 491255c6-465f-a78a-e063-6394a90aa408 | 2026-05-15 | Warnings | 73564-812-08 73564-812 73564081208 51dba85b-0b37-4d30-e063-6394a90a0773 491255c6-465f-a78a-e063-6394a90aa408 |
Adverse event summaries are temporarily unavailable. Other product information remains available.